Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Cancer, Combined Type”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02876510
What this trial is testing

ACTolog in Patients With Solid Cancers

Who this might be right for
CancerSolid Tumor
Immatics US, Inc. 38
Early research (Phase 1)Ended earlyNCT04173338
What this trial is testing

Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma

Who this might be right for
Non Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerUrothelial Carcinoma+1 more
Augusta University 9
Testing effectiveness (Phase 2)Study completedNCT03847519
What this trial is testing

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small CellMetastatic Squamous Cell CarcinomaMetastatic Non-Squamous Cell Carcinoma
Advaxis, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01310244
What this trial is testing

MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Acrotech Biopharma Inc. 23
Testing effectiveness (Phase 2)Ended earlyNCT03666728
What this trial is testing

SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC

Who this might be right for
Lung Neoplasms
Jiangsu HengRui Medicine Co., Ltd. 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05764928
What this trial is testing

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of Lung
Rgene Corporation 32
Testing effectiveness (Phase 2)Study completedNCT04731467
What this trial is testing

CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerPancreatic Cancer+4 more
Famewave Ltd. 79
Testing effectiveness (Phase 2)Study completedNCT04993677
What this trial is testing

SEA-CD40 Given With Other Drugs in Cancers

Who this might be right for
MelanomaCarcinoma, Non-Small- Cell Lung
Seagen Inc. 77
Testing effectiveness (Phase 2)Study completedNCT01642251
What this trial is testing

Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaLarge Cell Lung CarcinomaNeuroendocrine Carcinoma+2 more
National Cancer Institute (NCI) 156
Testing effectiveness (Phase 2)Active Not RecruitingNCT04079712
What this trial is testing

Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors

Who this might be right for
Metastatic Large Cell Neuroendocrine CarcinomaMetastatic Neuroendocrine CarcinomaMetastatic Neuroendocrine Neoplasm+1 more
National Cancer Institute (NCI) 17
Not applicableEnded earlyNCT00090961
What this trial is testing

S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer

Who this might be right for
Lung CancerPulmonary Complications
SWOG Cancer Research Network 2
Early research (Phase 1)UnknownNCT00324597
What this trial is testing

AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+1 more
Jonsson Comprehensive Cancer Center 18
Early research (Phase 1)Ended earlyNCT03265080
What this trial is testing

ADXS-NEO Expressing Personalized Tumor Antigens

Who this might be right for
Colon Cancer MetastaticHead and Neck Cancer MetastaticMetastatic Non-Small Cell Lung Cancer+2 more
Advaxis, Inc. 13
Large-scale testing (Phase 3)Study completedNCT00005838
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+3 more
National Cancer Institute (NCI) 756
Testing effectiveness (Phase 2)Ended earlyNCT03382899
What this trial is testing

Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 101
Early research (Phase 1)WithdrawnNCT03982134
What this trial is testing

PDR001 + Panobinostat for Melanoma and NSCLC

Who this might be right for
MelanomaNon Small Cell Lung Cancer
Muhammad Furqan
Early research (Phase 1)WithdrawnNCT00937417
What this trial is testing

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
SWOG Cancer Research Network
Not applicableStudy completedNCT01668108
What this trial is testing

A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer

Who this might be right for
Carcinoma
Onkovis GmbH 770
Testing effectiveness (Phase 2)Study completedNCT00006378
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00861627
What this trial is testing

Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation

Who this might be right for
Carcinoma, Non-small Cell Lung
Oncolytics Biotech 37
Next Page